5-HT4-like receptors in mammalian atria

  • A. J. Kaumann
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 34)


Atrial myocardium of man and pig possess receptors that mediate positive inotropic effects and/or positive chronotropic effects of 5- hydroxytryptamine (5-HT). These 5-HT receptors are blocked with moderate affinity (pKB = 6.7-6.9) by 3α-tropanyl-lH-indole-3-carboxylate (ICS 205930) but not by antagonists of α- and β-adrenoceptors, or 5-HT1 subtypes, 5-HT2 and 5-HT3 receptors. In human and porcine atrium the receptors also mediate 5-HT-induced increases of both cyclic AMP levels and cyclic AMP-dependent protein kinase activity. Human and porcine atrial 5-HT receptors are also partially activated by the benzamides renzapride and cisapride albeit with lower potency and efficacy than 5-HT. The properties of these atrial 5-HT receptors resemble those of “so called” 5-HT4 receptors, positively coupled to the adenylyl cyclase of mouse embyonic colliculi neurons. However, for colliculi 5-HT4 receptors the benzamides have greater efficacy and ICS 205930 lower affinity than for atrial 5-HT receptors. The atrial 5-HT receptors of man and pig are, therefore, designated 5-HT4-like receptors. Guinea-pig night atria appear to have a mixture of 5-HT3- and 5-HT4-like receptors involved in the mediation of positive chronotropic effects of 5-HT.


Positive Inotropic Effect Atrial Myocardium Human Atrium Lysergic Acid Diethylamide Positive Chronotropic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576PubMedCrossRefGoogle Scholar
  2. Docherty JR (1988) Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat. Naunyn-Schmiedebergs Arch Pharmacol 337: 1–8PubMedGoogle Scholar
  3. Dumuis A, Buhelal R, Sebben M, Cory R, Bockaert J (1988) A non-classical 5- hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34: 880–887PubMedGoogle Scholar
  4. Dumuis A, Sebben M, Bockaert J (1989) The gastro-intestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurones. Naunyn-Schmiedebergs Arch Pharmacol 340: 403–410PubMedCrossRefGoogle Scholar
  5. Fozard J (1984) MDL 72222, a potent and highly selective antagonist at neuronal 5- hydroxytryptamine receptors. Naunyn-Schmiedebergs Arch Pharmacol 326: 36–44PubMedCrossRefGoogle Scholar
  6. Fozard JR (1989) The development and early clinical evaluation of selective 5-HT3 receptor antagonists. In: Fozard JR (ed) The peripheral actions of 5- hydroxytryptamine. Oxford University Press, Oxford, pp 354–376Google Scholar
  7. Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol 12: 323–328Google Scholar
  8. Göthert M, Klupp N (1978) Cardiovascular effects of neurotoxic indolethylamines. Ann NY Acad Sci: 305: 457–477PubMedCrossRefGoogle Scholar
  9. Hall JA, Kaumann AJ, Brown MJ (1990) Selective Pi-adrenoceptor blockade enhances positive inotropic responses to endogenous catcholamines mediated through β2- adrenoceptors in human atrial myocardium. Circ Res 66: 1610–1623PubMedGoogle Scholar
  10. Heuring RE, Peroutka SJ (1987) Characteristics of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7: 894–903PubMedGoogle Scholar
  11. Kaumann AJ (1983) A classification of heart serotonin receptors. Naunyn-Schmiedebergs Arch 322: R42CrossRefGoogle Scholar
  12. Kaumann AJ (1985) Two classes of myocardial 5-hydroxytryptamine receptors that are neither 5-HT1 nor 5-HT2. J Cardiovasc Pharmacol 7 [Suppl 7]: S76–S78CrossRefGoogle Scholar
  13. Kaumann A J (1986) Further differences between 5-HT receptors of atrium and ventricle in cat heart. Br J Pharmacol 89: 546 PGoogle Scholar
  14. Kaumann AJ (1990) Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptors. Naunyn-Schmiedebergs Arch Pharmacol 342: 619–622PubMedGoogle Scholar
  15. Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1989a) A receptor for 5-hydroxytryptamine in human atrium. Br J Pharmacol 98: 664 PGoogle Scholar
  16. Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ (1989b) A comparison of the effects of adrenaline and noradrenaline on human heart: the role of β1 and β2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10 [Suppl B]: 29–37PubMedGoogle Scholar
  17. Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990a) Human atrial 5-HT receptors: similarity to rodent neuronal 5-HT4 receptors. Br J Pharmacol 100: 319 PGoogle Scholar
  18. Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990b) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100: 879 - 885PubMedGoogle Scholar
  19. Kaumann AJ, Sanders L, Brown MJ (1990c) Chronic (β-adrenoceptor blockade enhances positive inotropic responses to 5-hydroxytryptamine in human atrium. J Mol Cell Cardiol 22 [Suppl 111]: S2CrossRefGoogle Scholar
  20. Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1991a) A 5-HT4-like receptor in human right atrium. Naunyn-Schmiedebergs Arch Pharmacol 344: 150–159PubMedCrossRefGoogle Scholar
  21. Kaumann AJ, Brown AM, Raval P (1991b) Putative 5-HT4-like receptors in piglet left atrium. Br J Pharmacol 102: 98 PGoogle Scholar
  22. Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of 3H 5-hydroxytrptamine, 3H lysergic acid diethylamide and 3H spiperidol. Mol Pharmacol 16: 687–699Google Scholar
  23. Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M- receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126–131Google Scholar
  24. Saxena PR, Mylecharane EJ, Heiligers J (1985) Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors. Naunyn-Schmiedebergs Arch Pharmacol 330: 121–129PubMedCrossRefGoogle Scholar
  25. Trendelenburg U (1960) The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J Pharmacol Exp Ther 130: 450–460PubMedGoogle Scholar
  26. Van Nueten JM, Janssen PAJ, Van Beck J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effect of ketanserin (R 41468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218: 217–230PubMedGoogle Scholar
  27. Villalon CM, den Boer MO, Heiligers JPC, Saxena PR (1990) Mediation of 5- hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol 100: 665–667PubMedGoogle Scholar
  28. Walter M, Lemoine H, Kaumann AJ (1984) Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn-Schmiedebergs Arch Pharmacol 327: 159–175PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • A. J. Kaumann
    • 1
  1. 1.SmithKline Beecham Pharmaceuticals, Welwyn, and Clinical Pharmacology Unit, Department of MedicineUniversity of CambridgeUK

Personalised recommendations